VERVE THERAPEUTICS INC
COM
CUSIP: 92539P101
Institutional Holders3
Total Institutional Value$262,340
Total Shares Held47,330
Avg Position$87,447
Top 5 Holders %100.0%
Alpha-Weighted Score54.0
New Positions+0
Exited Positions-12
Top 15 Institutional Holders by Value
■ New ■ Increased ■ Decreased ■ Unchanged
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|---|---|---|---|---|
| DEKABANK DEUTSCHE GIROZENTRALE | High Conviction | Low Flow | $344 (0.1%) | 24,000 | - |
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q4 25 | 2 | $0.00B | 47,330 | $5.54 |
| Q3 25 | 12 | $0.01B | 1,142,929 | $6.88 |
| Q2 25 | 172 | $0.89B | 80,537,952 | $11.09 |
| Q1 25 | 191 | $0.38B | 85,540,069 | $4.39 |
| Q4 24 | 165 | $0.43B | 79,950,908 | $5.42 |
| Q3 24 | 172 | $0.37B | 79,531,964 | $4.63 |
| Q2 24 | 163 | $0.39B | 85,465,525 | $4.58 |
| Q1 24 | 162 | $1.07B | 85,468,664 | $12.47 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.